Report post

Will AstraZeneca pay absci $247 million?

The artificial intelligence (AI) deals keep coming. AstraZeneca is the latest drugmaker to open its wallet, agreeing to pay Absci up to $247 million to collaborate on the design of an anti-cancer antibody.

What is AstraZeneca partnering with absci?

Dec 04, 2023 Vancouver, WA, December 4, 2023 – Absci Corporation (Nasdaq: ABSI), a leader in generative AI antibody discovery, today announced a collaboration with AstraZeneca, a global biopharmaceutical company, to deliver an AI-designed antibody against an oncology target.

Why did AstraZeneca collaborate with absci?

The collaboration with Absci was an “exciting opportunity” to use the company’s antibody creation AI, said Puja Sapra, an AstraZeneca senior vice-president who leads biologics engineering research and development.

The World's Leading Crypto Trading Platform

Get my welcome gifts